It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Pannexins are single-membrane large-pore channels that release ions and ATP upon activation. Three isoforms of pannexins 1, 2, and 3, perform diverse cellular roles and differ in their pore lining residues. In this study, we report the cryo-EM structure of pannexin 3 at 3.9 Å and analyze its structural differences with pannexin isoforms 1 and 2. The pannexin 3 vestibule has two distinct chambers and a wider pore radius in comparison to pannexins 1 and 2. We further report two cryo-EM structures of pannexin 1, with pore substitutions W74R/R75D that mimic the pore lining residues of pannexin 2 and a germline mutant of pannexin 1, R217H at resolutions of 3.2 Å and 3.9 Å, respectively. Substitution of cationic residues in the vestibule of pannexin 1 results in reduced ATP interaction propensities to the channel. The germline mutant R217H in transmembrane helix 3 (TM3), leads to a partially constricted pore, reduced ATP interaction and weakened voltage sensitivity. The study compares the three pannexin isoform structures, the effects of substitutions of pore and vestibule-lining residues and allosteric effects of a pathological substitution on channel structure and function thereby enhancing our understanding of this vital group of ATP-release channels.
Pannexins are large pore channels involved in ion and ATP release. Here the authors use cryo-EM structures of Pannexins 1 and 3 to demonstrate the effects of distinct residue substitutions on channel structure and function.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details








1 Indian Institute of Science, Molecular Biophysics Unit, Bangalore, India (GRID:grid.464869.1) (ISNI:0000 0000 9288 3664)
2 Indian Institute of Science, Molecular Biophysics Unit, Bangalore, India (GRID:grid.464869.1) (ISNI:0000 0000 9288 3664); St. Jude Children’s Research Hospital, Memphis, USA (GRID:grid.240871.8) (ISNI:0000 0001 0224 711X)
3 Indian Institute of Science, Molecular Biophysics Unit, Bangalore, India (GRID:grid.464869.1) (ISNI:0000 0000 9288 3664); The University of Chicago, Department of Chemistry, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822)
4 Tata Institute of Fundamental Research, National Centre for Biological Sciences, Bangalore, India (GRID:grid.22401.35) (ISNI:0000 0004 0502 9283)